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ABSTRACT  
A  series  of  2-amino-5-aryl-5H-thiazolo[4,3-b]-l,3,4-thiadiazoles  were  synthesized  by  using  aromatic  aldehydes, 
thioglycolic  acid  and  thiosemicarbazide.  Equimolar  mixtures  of  aromatic  aldehydes  with  thioglycolic  acid  and 
thiosemicarbazide  in H2SO4  transform  into 2-amino-5-aryl-5H-thiazolo[4,3-b]-l,3,4-thiadiazoles. Structures of all 
synthesized compounds were confirmed by  FTIR, 
1H NMR  and mass spectral data. Fungicidal activity against two 
fungi Aspergillus niger and Candida albicans and bactericidal activity against two gram +ve bacteria Staphylococcus 
aureus, Escherichia fecalis and two gram –ve bacteria Escheridhia coli, Klebsiella pneumonia and found to be active 
against these microorganisms.  
KEYWORDS: Aromatic aldehydes, thioglycolic acid, thiosemicarbazide, 2-aryl-(4-oxothiazolidin-3-yl)thiourea, 
cyclodehydration, 2-amino-5-aryl-5H-thiazolo[4,3-b]-1,3,4-thiadiazoles, Antibacterial activity, Antifungal activity. 
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INTRODUCTION 
The  resistance  towards  available  drugs  is  rapidly 
becoming  a  major  worldwide  problem.  The  need  to 
design new compounds to deal with this resistance has 
become  one  of  the  most  important  areas  of  research 
today. Thiadiazole  is a versatile  moiety that exhibits a 
wide variety of biological activities. Thiadiazole moiety 
acts  as  “hydrogen  binding  domain”  and  “two-electron 
donor  system”.  It  also  acts  as  a  constrained 
pharmacophore.  Many  drugs  containing  thiadiazole 
nucleus  are  available  in  the  market  such  as 
acetazolamide,  methazolamide,  sulfamethazole,  etc. 
Thiadiazole can act as the bio-isosteric replacement of 
the  thiazole  moiety.  So  it  acts  like  third  and  fourth 
generation  cephalosporins,  hence  can  be  used  in 
antibiotic preparations. Thiadiazole is a 5-membered ring 
system containing two nitrogen and one sulphur atom. 
They occur in nature in four isomeric forms viz. 1,2,3-
thiadiazole;  1,2,5-thiadiazole;  1,2,4-thiadiazole  and 
1,3,4-thiadiazole.  The  1,3,4-thiadiazole  isomer  of 
thiadiazole  series and  its dihydro-derivatives provide a 
bulk of literature on thiadiazole. A glance at the standard 
reference work shows that more work has been carried 
out  on  the  1,3,4-thiadiazole  than  all  other  isomers 
combined. Members of this ring system have found their 
way  into  such  diverse  application  as  pharmaceuticals, 
oxidation inhibitors, cyanine dyes, & metal complexing 
agents. In past decades, thiadiazoles  have proved their 
potential in development of pharmaceutically important 
organic compounds both of natural and synthetic origin
1. 
Thiadiazole analogs deal with a variety of bioactivities 
viz.  antitumor
2-3,  anti-HIV
4,  antimicrobial
5-6, 
anticonvulsant
7,  antitubercular
8,  antiprotozoal
9,  anti-
inflammatory
10. Literature is enriched with lot of work 
on synthesis of potent substituted thiadiazole derivatives 
with diverse pharmacological activities
11-12 but only few 
reports  have  been  received  on  peptide  coupling  of 
thiadiazoles.  Thus  keeping  in  view  the  biological 
potency of thiadiazole derivatives a series of 2-amino-5-
aryl-5H-thiazolo[4,3-b]-l,3,4-thiadiazoles  with  an 
anticipation  to  get  potent  agents  of  more  therapeutic 
efficacy with lesser adverse effects. The wide range of M. Himaja et al / IJRAP 2011, 2 (1) 170-174 
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therapeutic  values  of    thiadiazoles  prompted  us  to 
synthesize the title compounds and screen them for their 
antimicrobial activities. 
Recently, N-substituted-2-amino-5-aryl-5H-thiazolo[4,3-
b]-1,3,4-thiadiazoles, active against pathogenic fungi of 
agricultural crops, have become substances, among other 
1,3,4-thiadiazoles,  that  have  drawn  the  attention  of 
researchers
13-15. The only known method giving rise to 
that heterocyclic system is based on cyclodehydration of 
(4-oxothiazolidine-3-yl)thioureas (in concentrated H2SO4 
medium),  which  in  turn  are  formed  upon 
cyclodehydration  of  the  products  of  addition  of 
thioglycolic  acid  to  the  azomethine  fragment  of 
arylthiosemicarbazones,  
MATERIALS AND METHODS 
Analytical  grade  solvents  and  commercially  available 
reagents  were  used  without  further  purification.  The 
column chromatography was carried out over silica gel 
(60-120  mesh),  purchased  from  Sisco  Research 
Laboratories Pvt Ltd. Melting points were determined in 
DBK,  Prog,  melting  point  apparatus  Servewell 
Instruments  Pvt  Ltd.  IR  spectra  in  KBr  disk  were 
recorded  from  4000  to  400  cm
-1  on  Shimadzu  FT-IR 
spectrometer. 
1H  NMR  spectra  were  recorded on  400-
MHz and 500-MHz Bruker spectrometer in CDCl3 using 
tetramethylsilane  (TMS)  as  an  internal  standard. 
Chemical  shifts  are  given  in  δ  relative  to  TMS,  the 
coupling constants are given in Hz. Mass spectra were 
recorded  using  Agilent  1100  MSD  spectrometer  in 
electro spray mode. 
 
General procedure of synthesis of compounds 5a--5j. 
An aromatic aldehyde (0.02 mole) and thioglycolic acid 
(0.02  mole)  were  mixed,  and  after  10--15  min.  0.022 
mole  of  thiosemicarbazide  was  added;  then  10  mL  of 
concentrated H2SO4 was added in portions upon cooling. 
The mixture was homogenized and left for 18--24 hours 
at -20 °C. The reaction mass was treated with 30--50 g 
ice,  the  precipitated  solid  was  decanted,  water  was 
added, and the obtained suspension was neutralized with 
40% NaOH until a weak alkaline reaction. Compounds 
3a--j were recrystallized from aqueous dioxane solution. 
2-Amino-5-phenyl-5H-thiazolo[4,3-b]-1,3,4-
thiadiazole (5a). yield 87%, m.p. 156-158
0C, yellowish 
crystals. IR spectrum (v/cm
-1): 3472 (-NH2); 3155(-CH 
aromatic); 2821 (-CH of thiazole); 
1H NMR spectrum (δ, 
ppm): 11.42 (s, CH);  8.19 (s, CH); 7.36-7.41 (m, Ph). 
MS spectrum, m/z: 236 [M+1]
 +.  
2-Amino-5-(4-methylphenyl)-5H-thiazolo[4,3-b]-1,3,4-
thiadiazole (5b). yield 88%, m.p. 173-174
0C, yellowish 
crystals. IR spectrum (v/cm
-1): 3402 (-NH2); 3155 (-CH 
aromatic); 2989 (-CH aliphatic); 2800 (-CH of thiazole); 
1H NMR spectrum (δ, ppm): 10.20 (s, CH); 6.56 (s, CH); 
7.18-7.55 (m, Ph); 2.37 (s, Me). MS spectrum, m/z: 250 
[M+1]
 +.  
2-Amino-5-(4-hydroxyphenyl)-5H-thiazolo[4,3-b]-
1,3,4-thiadiazole  (5c).  yield  85%,  m.p.  226-227
0C, 
yellow crystals. IR spectrum (v/cm
-1): 3471 (-NH2); 3360 
(-CH  aromatic;  2880  (-CH  of  thiazole); 
1H  NMR 
spectrum (δ, ppm): 11.14 (s, CH); 7.98 (s, CH);  5.55(s, 
OH) 7.08-7.74 (m, Ph). MS spectrum, m/z: 252 [M+1]
 +.  
2-Amino-5-(4-nitrophenyl)-5H-thiazolo[4,3-b]-1,3,4-
thiadiazole  (5d).  yield  87.3%,  m.p.  158-160 
0C, 
yellowish crystals. IR spectrum (v/cm
-1): 3491 (-NH2); 
3365 (-CH aromatic); 2995 (-CH of thiazole); 
1H NMR 
spectrum (δ, ppm): 11.14 (s, CH); 7.98 (s, CH);  7.05-
7.70 (m, Ph).  MS spectrum, m/z: 281 [M+1]
 +.  
2-Amino-5-(4-dimethylaminophenyl)-5H-thiazolo[4,3-
b]-1,3,4-thiadiazole  (5e).  yield  77%,  m.p.  209-210
0C, 
yellowish crystals. IR spectrum (v/cm
-1): 3440 (-NH2); 
3115 (-CH aromatic); 2960 (-CH aliphatic);  2880 (-CH 
of thiazole); 
1H NMR spectrum (δ, ppm): 10.20 (s, CH); 
8.27  (s,  CH);    7.16-7.30  (m,  Ph);  3.77  (s,  Me).  MS 
spectrum, m/z: 279 [M+1]
 +.  
2-Amino-5-(2-chlorophenyl)-5H-thiazolo[4,3-b]-1,3,4-
thiadiazole (5f). yield 82%, m.p. 214-215
0C, yellow 
crystals. IR spectrum (v/cm
-1): 3410 (-NH2); 3115 (-CH 
aromatic); 2800 (-CH of thiazole); 
1H NMR spectrum (δ, 
ppm): 11.14 (s, CH); 7.96 (s, CH);  7.08-7.74 (m, Ph). 
MS spectrum, m/z: 271 [M+1]
 +.  
2-Amino-5-(4-chlorophenyl)-5H-thiazolo[4,3-b]-1,3,4-
thiadiazole (5g). yield 91%, m.p. 207-208
0C, yellowish 
crystals. IR spectrum (v/cm
-1): 3449 (-NH2); 3282 (-CH 
aromatic); 2995 (-CH of thiazole); 
1H NMR spectrum (δ, 
ppm): 9.51 (s, CH); 6.4 (s, CH);  7.28-7.72 (m, Ph). MS 
spectrum, m/z: 271 [M+1]
 +.  
2-Amino-5-(2,4-dichlorophenyl)-5H-thiazolo[4,3-b]-
1,3,4-thiadiazole  (5h).  yield  89%,  m.p.  241-242
0C, 
Brownish yellow crystals. IR spectrum (v/cm
-1): 3456 (-
NH2); 3260 (-CH aromatic); 3020 (-CH of thiazole); 
1H 
NMR spectrum (δ, ppm): 9.25 (s, CH);  7.32-7.76 (m, 
Ph). MS spectrum, m/z: 305 [M+1]
 +.  
2-Amino-5-(2-methoxyphenyl)-5H-thiazolo[4,3-b]-
1,3,4-thiadiazole  (5i).  yield  69%,  m.p.  168-169
0C, 
yellowish crystals. IR spectrum (v/cm
-1): 3406 (-NH2); 
3288 (-CH aromatic); 3100 (-CH aliphatic);  2800 (-CH 
of thiazole); 
1H NMR spectrum (δ, ppm): 9.79 (s, CH); 
6.86  (s,  CH);    7.14-7.79  (m,  Ph),3.73  (s,  OCH3).  MS 
spectrum, m/z: 266 [M+1]
 +.  
2-Amino-5-(3-methoxyphenyl)-5H-thiazolo[4,3-b]-
1,3,4-thiadiazole  (5j).  yield  72%,  m.p.  212-213
0C, 
yellowish crystals. IR spectrum (v/cm
-1): 3417 (-NH2); 
3250 (-CH aromatic); 3000 (-CH aliphatic);  2800 (-CH 
of thiazole); 
1H NMR spectrum (δ, ppm): 9.55 (s, CH); M. Himaja et al / IJRAP 2011, 2 (1) 170-174 
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6.92  (s,  CH);  7.12-7.75  (m,  Ph);  3.77  (s,  OCH3).  MS 
spectrum, m/z: 265 [M+1]
 +.  
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RESULTS AND DISCUSSION 
Chemistry 
The  synthesis  of  the  finished  products  from  aromatic 
aldehydes,  thiosemicarbazide,  and  thioglycolic  acid 
involves three steps. We followed the Shukurov et al
16 
procedure for one-pot synthesis of 2-amino-5-aryl-5 H-
thiazolo[4,3-b]-1,3,4-thiadiazoles  (5a-5j)  (Scheme  1) 
from  equimolar  quantities  of  an  aromatic  aldehyde, 
thioglycolic acid, and thiosemicarbazide. The interaction 
between equimolar quantities of aromatic aldehydes and 
thioglycolic  acid  proceeds  with  heat  liberation  and 
probably results  in  semithioacetals of thioglycolic acid 
(1), which further react with thiosemicarbazide to give 
functionalized N,S-acetals (2). Thioureas 3 are obtained 
as  a  result  of  cyclodehydration  of  the  latter  in 
concentrated  H2SO4  medium;  they  transform  into 
compounds 5a-5j through intermediates 4. The structure 
of compounds 5a-5j was confirmed by IR, 
1H NMR and 
Mass spectroscopy. The IR spectra of these compounds 
have no absorption band in the region of 1680-1630 cm
-
1,  characteristic  of  the  stretching  vibrations  of  the 
carbonyl group of the amide fragment in compounds of 
type  3,  which  confirms  the  hydrothiazolo[4,3-b]-1,3,4-
thiadiazole structure. There are two absorption bands in 
the  region  3470-3400  cm
-1  and  3250-3220  cm
-1  that 
might  be  interpreted  as  asymmetric  and  symmetric 
stretching vibrations of the amino group. Four peaks, due 
to the CH-stretching vibrations of the aromatic ring, were 
recorded  in  the  interval  3180-2820  cm
-1.  An  intense 
absorption band is observed in the spectra at 1960 cm
-1,  
which can be assigned to the C-C normal vibrations of 
the aromatic ring. A group of the absorption bands in the 
1600-500 cm
-1 region is likely to be associated with the 
5-phenyl-5H-thiazolo[4,3-b]-1,3,4-thiadiazole  system. 
The methine proton signals and those of the proton in the 
5H-position of the thiazole ring are detected in the 
1H 
NMR spectra at 7.96--8.3 ppm. The resonance lines of 
the phenyl ring protons are observed at 7.08--8.27 ppm. 
Pharmacological Studies 
Antibacterial and Antifungal activity 
Compounds  5a-5j  were  screened  for  antibacterial  and 
antifungal activities using the Disc Diffusion  method
17 M. Himaja et al / IJRAP 2011, 2 (1) 170-174 
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by measuring the zone of inhibiton. A 24 h culture of 
bacterial  strains  of  S.  aureus,  E.  fecalis,  K.pneumonia 
and E. coli were cultivated in Brain   heart infusion agar 
medium  and  the  fungal  strains  of  A.  niger,  and  C. 
albicans  were  cultivated  in  Sabouraud  agar  medium 
respectively. All the compounds were tested at different  
concentration level. Dimethyl formamide was used as a 
solvent  and  as  control.  Ciprofloxacin  and  Fluconazole 
were used as a standard for comparison of the results. 
The  diameter  of  zone  of  inhibition  was  measured  in 
millimeter(mm)  after  24h  incubation  at  37
0C.  The 
Antimicrobial study results are tabulated in Table 1. 
CONCLUSION 
We  prepared  some  thiadiazoles  5a-5j  in  good  yields 
from  aromatic  aldehydes,  thioglycolic  acid  and 
thiosemicarbazide.  Equimolar  mixtures  of  aromatic 
aldehydes with thioglycolic acid and thiosemicarbazide 
in  H2SO4    transform  into  2-amino-5-aryl-5H-
thiazolo[4,3-b]-l,3,4-thiadiazoles  and  many  compounds 
from this series showed moderate to good antimicrobial 
activity at low concentrations. The biological profiles of 
these new generation of thiadiazoles would represent a 
fruitful  matrix  for  further  development  of  better 
antimicrobial agents. 
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Table 1:  Antibacterial and Antifungal activity of synthesized compounds 
 
 
Compounds 
MIC in µg/ml and zone of Inhibition  in mm  
    Gram +ve bacteria               Gram -ve bacteria                        Fungi tested 
S. aureus 
 
E. fecalis  K.pneumonia  E. coli  A. niger  C. albicans 
5a  50 (8-12)  50 (8-12)  25 (8-12)  50 (8-12)  50 (7-11)  25 (6-10) 
5b  50 (6-10)  75 (7-11)  50 (6-10)  50 (6-10)  50 (6-10)  50 (7-11) 
5c  75 (12-16)  75 (8-12)  50 (8-12)  75 (8-12)  75 (8-12)  25 (6-10) 
5d  50 (7-11)  75 (6-10)  50 (6-10)  75 (6-10)  50 (6-10)  50 (8-12) 
5e  75 (11-15)  75 (6-10)  50 (9-13)  75 (8-12)  50 (6-10)  50 (6-10) 
5f  50 (6-10)  75 (8-12)  50 (8-12)  75 (8-12)  75 (8-12)  75 (10-14) 
5g  75 (8-12)  75 (8-12)  75 (6-10)  75 (6-10)  75 (7-11)  75 (11-15) 
5h  75 (9-13)  75 (10-14)  75 (8-12)  75 (8-12)  75 (9-13)  50 (8-12) 
5i  75 (6-10)  75 (8-12)  75 (8-12)  75 (6-10)  75 (8-12)  50 (6-10) 
5j  75 (8-12)  75 (6-10)  75 (6-10)  75 (8-12)  75 (6-10)  50 (8-12) 
DMF 
(Control) 
-  -  -  -  -  - 
Ciprofloxacin 
(Standard) 
10 (24-28)  10 (25-29)  10 (28-32)  10 (30-34)  -  - 
Fluconazole 
(Standard) 
-  -  -  -  30 (24-28)  30 (22-26) 
 
The MIC values were evaluated at concentration range, 5-75 µg/ml. The figure in the table showed the value in µg/ml and the corresponding zone of inhibition in 
millimeter(mm). 
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